Cargando…
A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1
Oncolytic virotherapy is an emerging and promising treatment modality that uses replicating viruses as selective antitumor agents. Here, we report that a classical protein kinase A (PKA) inhibitor, H89, synergizes with oncolytic virus M1 in various cancer cells through activation of Epac1 (exchange...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217030/ https://www.ncbi.nlm.nih.gov/pubmed/27374176 http://dx.doi.org/10.18632/oncotarget.10305 |
_version_ | 1782492029811425280 |
---|---|
author | Li, Kai Liang, Jiankai Lin, Yuan Zhang, Haipeng Xiao, Xiao Tan, Yaqian Cai, Jing Zhu, Wenbo Xing, Fan Hu, Jun Yan, Guangmei |
author_facet | Li, Kai Liang, Jiankai Lin, Yuan Zhang, Haipeng Xiao, Xiao Tan, Yaqian Cai, Jing Zhu, Wenbo Xing, Fan Hu, Jun Yan, Guangmei |
author_sort | Li, Kai |
collection | PubMed |
description | Oncolytic virotherapy is an emerging and promising treatment modality that uses replicating viruses as selective antitumor agents. Here, we report that a classical protein kinase A (PKA) inhibitor, H89, synergizes with oncolytic virus M1 in various cancer cells through activation of Epac1 (exchange protein directly activated by cAMP 1). H89 substantially increases viral replication in refractory cancer cells, leading to unresolvable Endoplasmic Reticulum stress, and cell apoptosis. Microarray analysis indicates that H89 blunts antiviral response in refractory cancer cells through retarding the nuclear translocation of NF-κB. Importantly, in vivo studies show significant antitumor effects during M1/H89 combination treatment. Overall, this study reveals a previously unappreciated role for H89 and demonstrates that activation of the Epac1 activity can improve the responsiveness of biotherapeutic agents for cancer. |
format | Online Article Text |
id | pubmed-5217030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-52170302017-01-17 A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1 Li, Kai Liang, Jiankai Lin, Yuan Zhang, Haipeng Xiao, Xiao Tan, Yaqian Cai, Jing Zhu, Wenbo Xing, Fan Hu, Jun Yan, Guangmei Oncotarget Research Paper Oncolytic virotherapy is an emerging and promising treatment modality that uses replicating viruses as selective antitumor agents. Here, we report that a classical protein kinase A (PKA) inhibitor, H89, synergizes with oncolytic virus M1 in various cancer cells through activation of Epac1 (exchange protein directly activated by cAMP 1). H89 substantially increases viral replication in refractory cancer cells, leading to unresolvable Endoplasmic Reticulum stress, and cell apoptosis. Microarray analysis indicates that H89 blunts antiviral response in refractory cancer cells through retarding the nuclear translocation of NF-κB. Importantly, in vivo studies show significant antitumor effects during M1/H89 combination treatment. Overall, this study reveals a previously unappreciated role for H89 and demonstrates that activation of the Epac1 activity can improve the responsiveness of biotherapeutic agents for cancer. Impact Journals LLC 2016-06-27 /pmc/articles/PMC5217030/ /pubmed/27374176 http://dx.doi.org/10.18632/oncotarget.10305 Text en Copyright: © 2016 Li et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Li, Kai Liang, Jiankai Lin, Yuan Zhang, Haipeng Xiao, Xiao Tan, Yaqian Cai, Jing Zhu, Wenbo Xing, Fan Hu, Jun Yan, Guangmei A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1 |
title | A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1 |
title_full | A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1 |
title_fullStr | A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1 |
title_full_unstemmed | A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1 |
title_short | A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1 |
title_sort | classical pka inhibitor increases the oncolytic effect of m1 virus via activation of exchange protein directly activated by camp 1 |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217030/ https://www.ncbi.nlm.nih.gov/pubmed/27374176 http://dx.doi.org/10.18632/oncotarget.10305 |
work_keys_str_mv | AT likai aclassicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT liangjiankai aclassicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT linyuan aclassicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT zhanghaipeng aclassicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT xiaoxiao aclassicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT tanyaqian aclassicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT caijing aclassicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT zhuwenbo aclassicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT xingfan aclassicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT hujun aclassicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT yanguangmei aclassicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT likai classicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT liangjiankai classicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT linyuan classicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT zhanghaipeng classicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT xiaoxiao classicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT tanyaqian classicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT caijing classicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT zhuwenbo classicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT xingfan classicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT hujun classicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 AT yanguangmei classicalpkainhibitorincreasestheoncolyticeffectofm1virusviaactivationofexchangeproteindirectlyactivatedbycamp1 |